PET scan with [11C]erlotinib may provide noninvasive method to identify TKI-responsive lung tumors
Tuesday, July 5, 2011 - 04:00
in Health & Medicine
A non-invasive PET imaging technique may identify lung cancers that respond best to tyrosine kinase inhibitors (TKIs), allowing doctors to better select patients for personalized therapy, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).